These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15793115)

  • 21. Azithromycin retards Pseudomonas aeruginosa biofilm formation.
    Gillis RJ; Iglewski BH
    J Clin Microbiol; 2004 Dec; 42(12):5842-5. PubMed ID: 15583321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel cationic peptide TP359 down-regulates the expression of outer membrane biogenesis genes in Pseudomonas aeruginosa: a potential TP359 anti-microbial mechanism.
    Dosunmu EF; Chaudhari AA; Bawage S; Bakeer MK; Owen DR; Singh SR; Dennis VA; Pillai SR
    BMC Microbiol; 2016 Aug; 16(1):192. PubMed ID: 27549081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of outer membrane of Pseudomonas cepacia in aminoglycoside and polymyxin resistance.
    Moore RA; Hancock RE
    Antimicrob Agents Chemother; 1986 Dec; 30(6):923-6. PubMed ID: 3028253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract]   [Full Text] [Related]  

  • 25. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel targets of azithromycin activity against
    Belanger CR; Lee AH; Pletzer D; Dhillon BK; Falsafi R; Hancock REW
    Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33519-33529. PubMed ID: 33318204
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.
    Mugabe C; Halwani M; Azghani AO; Lafrenie RM; Omri A
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2016-22. PubMed ID: 16723560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A predicted S-type pyocin shows a bactericidal activity against clinical Pseudomonas aeruginosa isolates through membrane damage.
    Ling H; Saeidi N; Rasouliha BH; Chang MW
    FEBS Lett; 2010 Aug; 584(15):3354-8. PubMed ID: 20580355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of outer membrane permeability of Pseudomonas aeruginosa and bactericidal activity of endolysins KZ144 and EL188 under high hydrostatic pressure.
    Briers Y; Cornelissen A; Aertsen A; Hertveldt K; Michiels CW; Volckaert G; Lavigne R
    FEMS Microbiol Lett; 2008 Mar; 280(1):113-9. PubMed ID: 18248421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cations on the structure of bilayers formed by lipopolysaccharides isolated from Pseudomonas aeruginosa PAO1.
    Kucerka N; Papp-Szabo E; Nieh MP; Harroun TA; Schooling SR; Pencer J; Nicholson EA; Beveridge TJ; Katsaras J
    J Phys Chem B; 2008 Jul; 112(27):8057-62. PubMed ID: 18549267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model.
    Bulitta JB; Yang JC; Yohonn L; Ly NS; Brown SV; D'Hondt RE; Jusko WJ; Forrest A; Tsuji BT
    Antimicrob Agents Chemother; 2010 May; 54(5):2051-62. PubMed ID: 20211900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa.
    Srinivas N; Jetter P; Ueberbacher BJ; Werneburg M; Zerbe K; Steinmann J; Van der Meijden B; Bernardini F; Lederer A; Dias RL; Misson PE; Henze H; Zumbrunn J; Gombert FO; Obrecht D; Hunziker P; Schauer S; Ziegler U; Käch A; Eberl L; Riedel K; DeMarco SJ; Robinson JA
    Science; 2010 Feb; 327(5968):1010-3. PubMed ID: 20167788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa.
    Loh B; Grant C; Hancock RE
    Antimicrob Agents Chemother; 1984 Oct; 26(4):546-51. PubMed ID: 6440475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis.
    Orito Y; Morita M; Hori K; Unno H; Tanji Y
    Appl Microbiol Biotechnol; 2004 Jul; 65(1):105-9. PubMed ID: 14714151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the temperature-regulated acyltransferase (PA3242) on growth, antibiotic resistance and virulence in Pseudomonas aeruginosa.
    Liang Y; Guo Z; Gao L; Guo Q; Wang L; Han Y; Duan K; Shen L
    Microb Pathog; 2016 Dec; 101():126-135. PubMed ID: 27746380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patients.
    Solleti VS; Alhariri M; Halwani M; Omri A
    J Antimicrob Chemother; 2015 Mar; 70(3):784-96. PubMed ID: 25416744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa.
    Hubble VB; Hubbard BA; Minrovic BM; Melander RJ; Melander C
    ACS Infect Dis; 2019 Jan; 5(1):141-151. PubMed ID: 30444345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane.
    Hancock RE; Wong PG
    Antimicrob Agents Chemother; 1984 Jul; 26(1):48-52. PubMed ID: 6433788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Pseudomonas aeruginosa outer membrane permeability barrier and how to overcome it.
    Hancock RE
    Antibiot Chemother (1971); 1985; 36():95-102. PubMed ID: 2988427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.